This come out of a life science report dated 25/7
..Australian regenative medicine firm lands a great partner in China ........China addresses a significant opportunity for instance 17% of the 1.3+ billion people there have cardiovascular disease,around 500,000 individuals PER YEAR experience cardiac arrest due to air quality quaility, great incidents of smoking , and excessive salt intake ..It's estimated that cardiovascular disease drug market in China is around $45 Billion dollars in 2018 ...Cheers PS of course that's only an extract of the report ..
MSB trading, page-1066
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.33 |
Change
0.045(3.50%) |
Mkt cap ! $1.518B | |||
| Open | High | Low | Value | Volume |
| $1.30 | $1.35 | $1.30 | $2.885M | 2.183M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.33 | 7070 | 1 |
View Market Depth
| Last trade - 16.10pm 06/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |